PAK1 modulates a PPARγ/NF-κB cascade in intestinal inflammation

Dammann, Kyle, Khare, Vineeta, Lang, Michaela, Claudel, Thierry, Harpain, Felix, Granofszky, Nicolas, Evstatiev, Rayko, Williams, Jonathan M., Pritchard, D. Mark, Watson, Alastair and Gasche, Christoph (2015) PAK1 modulates a PPARγ/NF-κB cascade in intestinal inflammation. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1853 (10, Part A). 2349–2360. ISSN 0167-4889

[img]
Preview
PDF (Manuscript) - Published Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (2773kB) | Preview

    Abstract

    P21-activated kinases (PAKs) are multifunctional effectors of Rho GTPases with both kinase and scaffolding activity. Here, we investigated the effects of inflammation on PAK1 signaling and its role in colitis-driven carcinogenesis. PAK1 and p-PAK1 (Thr423) were assessed by immunohistochemistry, immunofluorescence, and Western blot. C57BL6/J wildtype mice were treated with a single intraperitoneal TNFα injection. Small intestinal organoids from these mice and from PAK1-KO mice were cultured with TNFα. NF-κB and PPARγ were analyzed upon PAK1 overexpression and silencing for transcriptional/translational regulation. PAK1 expression and activation was increased on the luminal intestinal epithelial surface in inflammatory bowel disease and colitis-associated cancer. PAK1 was phosphorylated upon treatment with IFNγ, IL-1β, and TNFα. In vivo, mice administered with TNFα showed increased p-PAK1 in intestinal villi, which was associated with nuclear p65 and NF-κB activation. p65 nuclear translocation downstream of TNFα was strongly inhibited in PAK1-KO small intestinal organoids. PAK1 overexpression induced a PAK1–p65 interaction as visualized by co-immunoprecipitation, nuclear translocation, and increased NF-κB transactivation, all of which were impeded by kinase-dead PAK1. Moreover, PAK1 overexpression downregulated PPARγ and mesalamine recovered PPARγ through PAK1 inhibition. On the other hand PAK1 silencing inhibited NF-κB, which was recovered using BADGE, a PPARγ antagonist. Altogether these data demonstrate that PAK1 overexpression and activation in inflammation and colitis-associated cancer promote NF-κB activity via suppression of PPARγ in intestinal epithelial cells.

    Item Type: Article
    Additional Information: Open Access funded by Austrian Science Fund (FWF) Under a Creative Commons license (CC BY-NC-ND)
    Uncontrolled Keywords: pak1,nf-kb,ppary,inflammation,ulcerative colitis,colitis-associated cancer
    Faculty \ School: Faculty of Medicine and Health Sciences > Norwich Medical School
    University of East Anglia > Faculty of Medicine and Health Sciences > Research Groups > Gastroenterology and Gut Biology
    Depositing User: Pure Connector
    Date Deposited: 24 Jul 2015 23:46
    Last Modified: 21 Aug 2018 16:31
    URI: https://ueaeprints.uea.ac.uk/id/eprint/53688
    DOI: 10.1016/j.bbamcr.2015.05.031

    Actions (login required)

    View Item